Refine by
Targeted Biopsy Articles & Analysis
7 news found
Targeted MRI-US fusion biopsy is an emerging technology with the potential to change the standard of care for diagnosis and treatment. ...
Compared to standard systematic biopsies, MRI-targeted fusion biopsies improve the detection of clinically significant prostate cancer. ...
Increasingly, it is recommended for diagnosis if the initial biopsy is negative, but could be potentially more valuable as a triage test, deciding who needs a biopsy and how it may best be conducted.5 The EAU (European Association of Urology) recommends the use of MRI for both biopsy naive and previously negative patients, where men with PI-RADS ...
Wiemer et al. 2020, European Urology Focus: Micro-Ultrasound targeted biopsy found a higher-grade cancer in 26% of patients compared to non-targeted samples and MRI targeted samples in this single-center experience. ...
TORONTO, CANADA -- (March 23, 2021) Exact Imaging (www.exactimaging.com), the world’s leader in high resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance for the prostate, announces $5.1M in financing provided by BDC Capital, through the Bridge Financing Program, and Export Development Canada (EDC). ...
About Exact Imaging Exact Imaging (www.exactimaging.com) is the world’s leader in high-resolution micro-ultrasound systems enabling real-time imaging and guided biopsies in the urological market for prostate cancer. Exact Imaging’s ExactVu™ micro-ultrasound platform operates at 29 MHz and enables a whole new level of resolution with the benefits of ease of use, ...
oVio’s 360-degree dimensional imaging technology brings precise navigation and accurate targeting to robotic medical and aesthetic procedures. AVRA will utilize oVio’s imaging technology to “robotize” a wide range of medical procedures that are currently being performed by human hands, such as: biopsies, tissue targeting, ...